These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1818058)
1. Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection. Foglia JP; Sorisio D; Perel JM J Chromatogr; 1991 Dec; 572(1-2):247-58. PubMed ID: 1818058 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics. Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography. Chen AG; Wing YK; Chiu H; Lee S; Chen CN; Chan K J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):153-8. PubMed ID: 9200529 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatography of imipramine and six metabolites in human plasma and urine. Nielsen KK; Brøsen K J Chromatogr; 1993 Jan; 612(1):87-94. PubMed ID: 8454708 [TBL] [Abstract][Full Text] [Related]
5. Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method. Zeugin TB; Brosen K; Meyer UA Anal Biochem; 1990 Aug; 189(1):99-102. PubMed ID: 2278396 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. Suckow RF; Cooper TB J Pharm Sci; 1981 Mar; 70(3):257-61. PubMed ID: 7264887 [TBL] [Abstract][Full Text] [Related]
7. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry. Narasimhachari N; Saady J; Friedel RO Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616 [TBL] [Abstract][Full Text] [Related]
8. Active metabolites of imipramine and desipramine in man. Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321 [TBL] [Abstract][Full Text] [Related]
9. Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection. Kenney JT; Orsulak PJ; Kolodner RM; Burton ME Clin Chem; 1989 Oct; 35(10):2134-6. PubMed ID: 2791284 [TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites. Sutfin TA; Jusko WJ J Pharm Sci; 1979 Jun; 68(6):703-5. PubMed ID: 458567 [TBL] [Abstract][Full Text] [Related]
11. Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line. Su P; Coutts RT; Baker GB; Daneshtalab M Xenobiotica; 1993 Nov; 23(11):1289-98. PubMed ID: 8310712 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of imipramine and metabolites in 68 hospitalized children. Preskorn SH; Bupp SJ; Weller EB; Weller RA J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):373-5. PubMed ID: 2738003 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic monitoring of imipramine and desipramine by micellar liquid chromatography with direct injection and electrochemical detection. Bose D; Martinavarro-Domínguez A; Gil-Agustí M; Carda-Broch S; Durgbanshi A; Capella-Peiró ME; Esteve-Romero J Biomed Chromatogr; 2005 Jun; 19(5):343-9. PubMed ID: 15586373 [TBL] [Abstract][Full Text] [Related]
14. Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics. Brøsen K; Gram LF; Klysner R; Bech P Eur J Clin Pharmacol; 1986; 30(1):43-9. PubMed ID: 3709631 [TBL] [Abstract][Full Text] [Related]
15. Imipramine metabolites in blood of patients during therapy and after overdose. Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388 [TBL] [Abstract][Full Text] [Related]
16. The analysis and disposition of imipramine and its active metabolites in man. Sutfin TA; DeVane CL; Jusko WJ Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820 [TBL] [Abstract][Full Text] [Related]
17. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine. Spina E; Arena A; Pisani F Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150 [TBL] [Abstract][Full Text] [Related]
18. Rapid microsample analysis of imipramine and desipramine by reversed-phase high-performance liquid chromatography with ultraviolet detection. Yoo SD; Holladay JW; Fincher TK; Dewey MJ J Chromatogr B Biomed Appl; 1995 Jun; 668(2):338-42. PubMed ID: 7581871 [TBL] [Abstract][Full Text] [Related]
19. Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography. Suckow RF; Cooper TB J Chromatogr; 1988 Jun; 427(2):287-94. PubMed ID: 3410912 [TBL] [Abstract][Full Text] [Related]
20. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients. Belvedere G; Burti L; Frigerio A; Pantarotto C J Chromatogr; 1975 Sep; 111(2):313-21. PubMed ID: 1159010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]